About Us

RenovoRx, headquartered in Silicon Valley, California, has developed a platform technology to deliver small molecule therapeutic agents, such as chemotherapy, to specific sites in the body. Targeted therapy via proprietary Trans-Arterial Micro-Perfusion (TAMP) safely and without transmission to non-targeted areas, is the focus of the RenovoRx technology platform.

After demonstrating in a clinical study a median survival of approximately 28 months vs.14-15 months reported in historical studies for this patient population in Phase I/II pancreatic cancer studies, RenovoRx secured two separate Orphan Drug Designations from the FDA for Intra-Arterial gemcitabine: pancreatic cancer and bile duct cancer. This therapy is being further studied in the Phase III TIGeR-PaC trial evaluating extended median overall survival and improved quality of life for pancreatic cancer patients.

The randomized TIGeR-PaC trial is enrolling unresectable locally-advanced pancreatic cancer patients in the United States and Europe.

Management Team

Shaun R. Bagai

Shaun R. Bagai

Chief Executive Officer
Ramtin Agah, MD

Ramtin Agah, MD

Chief Medical Officer, Founder
Kamran Najmabadi

Kamran Najmabadi

Founder, Technical Engineering Advisor

Paul Manners

Chief Financial Officer
Imtiaz Qureshi, MD

Imtiaz Qureshi, MD

Director of Imaging

Nicole Lama

Director of Clinical Operations and Research

Board of Directors

Shaun R. Bagai

Shaun R. Bagai

Chief Executive Officer
Ramtin Agah, MD

Ramtin Agah, MD

Chief Medical Officer, Founder
Laurence J. Marton, MD

Laurence J. Marton, MD

Director
Una S. Ryan, PhD, OBE

Una S. Ryan, PhD, OBE

Director
Maky Zanganeh

Maky Zanganeh, DDS, MBA

Director

Angela Macfarlane

Director

Advisory Board

Jacob Cynamon, MD

Jacob Cynamon, MD

Professor of Clinical Radiology, Albert Einstein College of Medicine Chief, Division of Vascular and Interventional RadiologyProgram Director, Vascular and Interventional Radiology Fellowship Program Montefiore Medical Center, Bronx, NY
Mike Pishvaian, MD, PhD

Mike Pishvaian, MD, PhD

Associate Professor, Department of Oncology Director of the Gastrointestinal, Developmental Therapeutics, and Clinical Research Programs at the NCR Kimmel Cancer Center at Sibley Memorial Hospital Johns Hopkins University School of Medicine
Peter Muscarella, MD

Peter Muscarella, MD

Director, Pancreatic Surgery General Surgery Site Director, Weiler Hospital

Associate Program Director, General Surgery Residency Training Program Montefiore Medical Center, Bronx, NY

Karyn A. Goodman, MD, MS

Karyn A. Goodman, MD, MS

Professor and Vice Chair of Clinical Research, Department of Radiation Oncology, Icahn School of Medicine at Mount Sinai
Associate Director of Clinical Research, The Tisch Cancer Institute at Mount Sinai
Daniel D. Von Hoff, MD, FACP

Daniel D. Von Hoff, MD, FACP

Physician in Chief and Director of Translational Research at TGen (Translational Genomics Research Institute)

Chief Scientific Officer for US Oncology and for HonorHealth’s Clinical Research Institute

Clinical Professor of Medicine, University of Arizona, Tucson, AZ

Reza Malek, MD, MSc

Reza Malek, MD, MSc

Neurointerventional Radiologist, Minimally Invasive Surgical Solutions San Jose, CA
Menu